What are PDPs?

PDPs are:

• Nonprofit organisations that develop appropriate and affordable innovative tools for populations affected by PRNDs.

• Public health-driven and focused on patients’ needs in designing product for use in low- and middle-income countries with a high disease burden.

• Are working along the product development continuum from early discovery to product implementation, covering specific research gaps or the full innovation cycle.

• Employing a portfolio approach to R&D to accelerate product development by pursuing multiple strategies for a disease area and allowing only the most promising products to move forward.

PDPs are engaged as partners with academic and public research institutions, the private sector, governments, and civil society organisations—including partners in developing countries. As well as developing new products, PDP’s stimulate/support medical research in developing countries that includes linking scientists across the North-South divide.

click here for more details on the characteristics of PDPs

Stand alone single or multi disease PDPs with more than one funder

• Drugs for Neglected Diseases initiative (DNDi)

• European Vaccine Initiative (EVI)

• Foundation for Innovative New Diagnostics (FIND)

• Global Alliance for TB Drug Development (TB Alliance)

• Global Antibiotic Research & Development Partnership (GARDP)

• International AIDS Vaccine Initiative (IAVI)

• International Vaccine Institute (IVI)

• Innovative Vector Control Consortium (IVCC)

• Medicines Development for Global Health

• Medicines for Malaria Venture (MMV)